Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - PURESPECTRUM, INC.psruexh321march2011.htm
EX-31.1 - EXHIBIT 31.1 - PURESPECTRUM, INC.psruexh311march2011.htm
EX-31.2 - EXHIBIT 31.2 - PURESPECTRUM, INC.psruexh312march2011.htm
EX-32.2 - EXHIBIT 32.2 - PURESPECTRUM, INC.psruexh322march2011.htm





 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C., 20549

Form 10-Q
(Mark One)

ý
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2011

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___________ to _____________

Commission File Number: 333-1418158

PURESPECTRUM, INC.
(Exact Name of Registrant as Specified in Its Charter)

Delaware
41-2233202
(State or Other Jurisdiction of
Incorporation or Organization)
(I.R.S. Employer
Identification No.)
 
118 Pipemakers Circle
Suite 105
Pooler, GA 31322
(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code:                  (912) 308-0108[Missing Graphic Reference]
Indicate by check mark whether the Registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.          Yes ý          No o

Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate website, if any, every interactive data file required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes o          No o

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
(Check one):
Large accelerated filer     Accelerated filer     Non-accelerated filer     Smaller reporting company ý

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).          YES  NO ý
 
As of May 16, 2011 there were 486,650,842 shares of our $0,0001 par value common stock issued and outstanding.

 
 

 

.

Available Information

Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and all amendments to those reports that we file with the Securities and Exchange Commission, or SEC, are available at the SEC's public reference room at 100 F Street, N.E., Washington, D.C. 20549. The public may obtain information on the operation of the public reference room by calling the SEC at 1-800-SEC-0330. The SEC also maintains a website at www.sec.gov that contains reports, proxy, and information statements and other information regarding reporting companies.

TABLE OF CONTENTS

       
Page
     
PART I
   
 
ITEM 1.
 
Condensed Financial Statements (unaudited)
   
     
Balance Sheets as of March 31, 2011 and December 31, 2010
 
1
     
Statements of Operations for the Six Months Ended March 31, 2011 and 2010
 
2
     
Statements of Cash Flows for the Six Months Ended March 31, 2011 and 2010
 
3
     
Statements of Changes in Stockholders’ Deficit for the Period From  December 31, 2010 through March 31, 2011
 
4
     
Notes to Condensed Financial Statements
 
5-6
           
 
ITEM 2.
 
Management's Discussion and Analysis of Financial Condition and Results of Operations
 
7
 
ITEM 3.
 
Quantitative and Qualitative Disclosures About Market Risk (Not Applicable)
 
8
 
ITEM 4.
 
Controls and Procedures
 
8
     
 
PART II
   
 
ITEM 1.
 
Legal Proceedings
 
8
 
ITEM 1A.
 
Risk Factors (Not Applicable)
 
8
 
ITEM 2.
 
Unregistered Sales of Equity Securities and Use of Proceeds
 
8
 
ITEM 3.
 
Defaults Upon Senior Securities
 
9
 
ITEM 4.
 
[Removed and Reserved]
   
           
 
ITEM 5.
 
Other Information
 
9
 
ITEM 6.
 
Exhibits
 
9
     
SIGNATURES
 
9
 

 
 

 

PART I

Item 1.  Condensed Financial Statements




PureSpectrum, Inc.
 
Condensed Balance Sheets
 
             
   
March 31, 2011
 
December 31, 2010
 
   
(Unaudited)
   
(Unaudited)
 
Assets
 
Current Assets
           
Cash
  $ 1,762     $ 31,294  
Accounts Receivables
    1,092       1,659  
Inventory
    31,775       69,568  
Other Current Assets
    10,643       12,145  
Total Current Assets
    45,272       114,666  
                 
Furniture & Equipment, net of accumulated depreciation
    176,331       187,910  
                 
Other Assets
               
Patents, net of accumulated amortization
    585,361       586,613  
Trademarks
    164,110       164,110  
Total Assets
  $ 971,074     $ 1,053,299  
                 
Liabilities and Stockholders' Deficit
 
Current Liabilities
               
Checks Drawn In Excess of Bank Balance
    -       -  
Accounts Payable
    1,253,659       1,263,065  
Accrued Expenses
    321,317       290,690  
Payroll Liabilities
    243,853       243,853  
Convertible Debt, current portion, net of discount $113,938 and  $0, respectively
    724,988       591,540  
Notes Payable, current poriton
    224,305       224,305  
Notes Payable-Related parties, current poriton
    61,650       61,650  
Total Current Liabilities
    2,829,772       2,675,103  
                 
Long-term Liabilities
               
Accounts Payable, satisfied by common stock issuance
    -       -  
Accrued expenses, satisfied by common stock issuance
    -       -  
Notes Payable-Related parties, satisfied by common stock issuance
    -       -  
Convertible Debentures, net of discount $586,950 and $670,800, respectively
    531,050       447,200  
Total Long-term Liabilities
    531,050       447,200  
                 
Stockholders' Deficit
               
Preferred Stock, $0.0001 Par Value, 50,000,000 Shares Authorized, 2,000,000 and 0 Shares Issued and Outstanding at March 31, 2011 and December 31, 2010, respectively
    200       200  
Common Stock, $0.0001 Par Value, 900,000,000 Shares Authorized, 486,650,842 and 434,150,842 Shares Issued at March 31, 2011 and December 31, 2010, respectively
    48,666       43,416  
Additional Paid In Capital
    20,306,221       20,241,473  
Treasury Stock
    (170,000 )     (170,000 )
Prepaid Loan Costs
    -       -  
Accumulated Deficit
    (22,574,835 )     (22,184,093 )
Total Stockholders' Deficit
    (2,389,748 )     (2,069,004 )
Total Liabilities and Stockholders' Deficit
  $ 971,074     $ 1,053,299  
                 
                 
The accompanying notes are an integral part of the condensed financial statements.
         
                 

 
1

 





PureSpectrum, Inc.
 
Condensed Statements of Operations (Unaudited)
 
               
     
For the three months ended March 31,
 
     
2011
   
2010
 
               
Revenues
    $ 25,682     $ 9,079  
                   
Cost of Goods Sold
      35,732       6,497  
                   
Gross Profit on Sales
    $ (10,050 )   $ 2,582  
                   
Expenses
                 
Share Based Compensation
      -       262,738  
Research and Development
      -       131,743  
Other General and Administrative Expenses
      89,826       1,210,756  
Total Expense
      89,826       1,605,237  
Net Loss from Operations
      (99,876 )     (1,602,655 )
                   
Other (Expense) Income
                 
Interest Income
      -       -  
Gain on AP Settlement
      -       -  
Loss on Asset Disposal
      -       -  
Inventory Impairment Write Down
      -       -  
Interest Expense
      (290,866 )     (709,782 )
Total Other (Expense) Income
      (290,866 )     (709,782 )
Net Loss
    $ (390,742 )   $ (2,312,437 )
                   
Weighted Average Basic & Fully Diluted Outstanding Shares
      436,938,513       222,189,477  
                   
Basic & Fully Diluted Loss per Share
    $ (0.00 )   $ (0.01 )
                   
The accompanying notes are an integral part of the condensed financial statements.
               
                   




 
2

 

PureSpectrum, Inc.
 
Condensed Statements of Cash Flow (Unaudited)
 
                 
   
For the three months ended March 31
 
   
2011
       
2010
 
Operating activities
               
Net loss
  $ (390,742 )       $ (2,312,437 )
Adjustments to reconcile net loss to net cash
                   
used by operating activities:
                   
Depreciation and amortization
    12,831           11,681  
Share based compensation
    -           262,738  
Amortization of detachable warrants issued with convertible debt
    -           378,410  
Amortization of the beneficial conversion feature
    259,797           173,864  
Services exchanged for common stock
    -           135,000  
Stock issued for commitment fee collateral
    -           250,000  
Amortization of prepaid loan costs
    -           106,805  
Gain on Settlement of Accounts Payable
    -           -  
Loss on disposal od assets
    -           -  
(Increase) decrease in:
    -           -  
Accounts receivables
    567           (770 )
Inventory
    207,833           7,310  
Other current assets
    1,502           (9,506 )
Increase (decrease) in:
    -           -  
Accounts payable
    (179,446 )         (240,027 )
Accrued expenses
    30,626           15,773  
Payroll liabilities
    -           10,425  
Total adjustments
    333,710           1,101,703  
Net cash used by operating activities
    (57,033 )         (1,210,734 )
                     
Investing Activities
                   
Purchase of furniture and equipment
    -           (17,718 )
Development of Patents and trademarks
    -           -  
Purchase of Treasury Stock
    -           -  
Net cash used by investing activities
    -           (17,718 )
`
                   
Cash Flows from Financing Activities
                   
Increase in Checks Drawn in Excess of Bank Balance
    -           105,400  
Proceeds from borrowing
    27,500           218,000  
Proceeds from issuance of stock issued for conversion of debt
    -           -  
Repayment of borrowing
    -           (5,000 )
Proceeds from issuance of common stock
    -           329,593  
Proceeds from exersice of options and warrants
    -           580,100  
Proceeds from debt converted to common stock
    -           -  
Net cash provided by financing activities
    27,500           1,228,093  
                     
Net (Decrease) Increase in Cash
    (29,533 )         (359 )
                     
Cash at Beginning of Period
    31,294           609  
                     
Cash at End of Period
  $ 1,762         $ 250  
                     
Supplemental disclosures of cash flow information and
                   
noncash investing and financing activities:
                   
Debt and accrued interest converted to common stock
  $ 42,500         $ 221,979  
Satisfaction of accounts payable through issuance of common stock
  $ -         $ 200,000  
Cancellation of PSPM shares not exchanged for PSRU shares
  $ -         $ 7  
Detachable warrants issued with convertible debt
  $ -         $ 271,763  
Benefical conversion feature of convertible debt
  $ 27,500         $ 406,416  
Property and equipment additions included in accounts payable
  $ -         $ 422  
Inventory additions included in accounts payable
  $ 170,040         $ 155,104  
Intangible asset additions included in accounts payable
  $ -         $ 1,394  
                     
                     
The accompanying notes are an integral part of the condensed financial statements.
             
                     





 
3

 
PureSpectrum, Inc.
 
Statements of Changes in Stockholders' Deficit
 
For the Period From December 31, 2009 through March 31, 2011
   
                                 
 
Preferred Shares
 
Preferred Amount
 
Common Shares
 
Common Amount
 
Additional Paid in Capital
Prepaid Loan Costs
 
Accumulated Deficit
 
Treasury Stock
Total Stockholders' Deficit
 
Balance - December 31, 2009
-   $ -   215,455,090   $ 21,546   $ 13,875,015 $ (106,805 ) $ (14,211,159 ) $ - $ (421,403 )
                                               
Stock Issued for Cash(Unaudited)
-     -   12,571,312     1,257     328,336   -     -     -   329,593  
Stock Issued for Services (Unaudited)
2,000,000     200   2,616,667     262     134,738   -     -     -   135,200  
Share Based Compensation (Unaudited)
-     -   45,000,000     4,500     635,312   -     -     -   639,812  
Issuance of warrants and BCF associated with convertible debt (Unaudited)
-     -   -     -     2,341,491   -     -     -   2,341,491  
Stock issued upon exercise of warrants and options (Unaudited)
-     -   25,694,662     2,570     627,530   -     -     -   630,100  
Stock issued upon debt conversion (Unaudited)
-     -   122,648,521     12,265     1,845,066   -     -     -   1,857,331  
Stock issued upon redemption of convertible debentures (Unaudited)
-     -   233,333     23     34,977   -     -     -   35,000  
Stock issued for commitment fee collateral (Unaudited)
-     -   10,000,000     1,000     249,000   -     -     -   250,000  
Amortization of Prepaid Loan Costs (Unaudited)
-     -   -     -     -   106,805     -     -   106,805  
Cancellation of expired stock (Unaudited)
-     -   (68,743 )   (7 )   7   -     -     -   -  
Purchase of treasury stock (Unaudited)
-     -   -     -     -   -     -     (170,000   (170,000 )
Net Loss (Unaudited)
-     -   -     -     -   -     (7,972,931 )   -   (7,972,931 )
Balance - December 31, 2010 (Unaudited)
2,000,000   $ 200   434,150,842   $ 43,416   $ 20,071,472 $ -   $ (22,184,090 ) $ (170,000 $ (2,239,002 )
                                               
Stock Issued for Cash (Unaudited)
-     -   -     -     -   -     -     -   -  
Stock Issued for Services (Unaudited)
-     -   -     -     -   -     -     -   -  
Share Based Compensation (Unaudited)
-     -   -     -     -   -     -     -   -  
Issuance of warrants and BCF associated with convertible debt (Unaudited)
-     -   -     -     27,500   -     -     -   27,500  
Stock issued upon exercise of warrants and options (Unaudited)
-     -   -     -     -   -     -     -   -  
Stock issued upon debt conversion (Unaudited)
-     -   52,500,000     5,250     37,250   -     -     -   42,500  
Stock issued upon redemption of convertible debentures (Unaudited)
-     -   -     -     -   -     -     -   -  
Stock issued for commitment fee collateral (Unaudited)
-     -   -     -     -   -     -     -   -  
Amortization of Prepaid Loan Costs (Unaudited)
-     -   -     -     -   -     -     -   -  
Cancellation of expired stock (Unaudited)
-     -   -     -     -   -     -     -   -  
Purchase of treasury stock (Unaudited)
-     -   -     -     -   -     -     -   -  
Net Loss (Unaudited)
-     -   -     -     -   -     (390,742 )   -   (390,742 )
Balance - March 31, 2011 (Unaudited)
2,000,000   $ 200   486,650,842   $ 48,666   $ 20,136,222 $ -   $ (22,574,832 ) $ (170,000 $ (2,559,744 )
                                               
The accompanying notes are an integral part of the financial statements.
 
 
4

 

NOTES TO CONDENSED FINANCIAL STATEMENTS (unaudited)
 
NOTE 1 - BASIS OF PRESENTATION
 
The accompanying unaudited financial statements were prepared in accordance with instructions for Form 10-Q and, therefore, do not include information or footnotes necessary for a complete presentation of financial condition, results of operations, and cash flows in conformity with U.S. Generally Accepted Accounting Principles US GAAP.  All adjustments, consisting of normal recurring accruals, which, in the opinion of management, are necessary for fair presentation of the financial statements, have been included.  The results of operations for the period ended March 31, 2011, are not necessarily indicative of the results which may be expected for the entire fiscal year or for any other period.  For further information, refer to the financial statements and footnotes thereto for the year ended December 31, 2010 included in PureSpectrum Inc.'s Form 10-K.
 
Certain prior year amounts have been reclassified to conform to the 2011 presentation.
 
NOTE 2 – RECENT ACCOUNTING PRONOUNCEMENTS
 
The Company’s management does not believe that recent codified pronouncements by the Financial Accounting Standards Board FASB will have a material impact on the Company’s current or future financial statements.
 
NOTE 3 - SUMMARY OF ORGANIZATION
 
PureSpectrum, Inc. (the “Company”), formerly International Medical Staffing, Inc., is a Delaware corporation incorporated on March 21, 2007. The Company is in the business of developing, marketing, licensing, and contract manufacturing of lighting technology for use in residential, commercial, and industrial applications worldwide.
 
The Company is authorized to issue 950 million shares, consisting of (a) 900 million shares of common stock, par value $0.0001 per share and (b) 50 million shares of preferred stock, par value $0.0001 per share, which may be issuable in one or more series.  Each common share is entitled to one vote and shareholders have no preemptive or conversion rights. As of March 31, 2011, and December 31, 2010, there were 486,650,842 and 351,691,363 common shares issued and outstanding, respectively. The Company's Board of Directors may, without further action by the shareholders, direct the issuance of preferred stock for any proper corporate purpose with preferences, voting powers, conversion rights, qualifications, special or relative rights and privileges which could adversely affect the voting power or other rights of shareholders of common stock. As of March 31, 2011, and December 31, 2010, there were 2,000,000 and 2,000,000 shares of the Company's preferred stock issued or outstanding, respectively.  Each Series B preferred share entitles the holder thereof to five hundred (500) votes per share and may vote on any action requiring any class of shares to vote.
 
NOTE 4 – GOING CONCERN
 
The accompanying financial statements have been prepared in conformity with US GAAP, which contemplate continuation of the Company as a going concern and the realization of assets and liquidation of liabilities in the normal course of business.  The Company has incurred net losses from operations of $390,742 for the three months ended March 31, 2011.  In addition, at March 31, 2011, the Company has an accumulated deficit of $22,574,835 and negative working capital of $2,784,500.
 
These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern.
 
The Company recorded its first revenues in October 2009 and is no longer a development stage company.  The Company has not yet generated sufficient working capital to support its operations.  The Company’s ability to continue as a going concern is dependent, among other things, on its ability to minimize costs, enter into revenue generating contracts and obtain additional revenues to eventually attain a profitable level of operations.
 
The Company has been engaged in developing, marketing, licensing, and contract manufacturing of fluorescent lighting technology for use in residential, commercial, and industrial applications worldwide.  There can be no assurance that the Company will be successful in the commercialization of the fluorescent lighting technology that will generate sufficient revenues to sustain the operations of the Company.
 
Management plans to obtain additional capital investments to enable the Company to continue operations and increase revenues in 2011. There is no assurance that management will be able to successfully generate revenue and/or reduce expenses sufficient to attain profitability, or continue to attract the capital necessary to support the business.
 
NOTE 5 - NET LOSS PER SHARE
 
Basic net loss per share is computed by dividing net loss attributable to commons shareholders by the weighted average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted net loss per share reflects the potential dilution that could occur if securities were exercised or converted into common stock using the treasury stock method. Diluted net loss per share is computed by dividing the net loss by the weighted average number of common share equivalents outstanding for the period determined using the treasury-stock method. For purposes of this calculation, convertible preferred stock, stock options and warrants are considered to be common stock equivalents and are only included in the calculation of diluted net loss per share when their effect is dilutive.
 
 
Three months ended
       
 
March 31,
       
   
2011
   
2010
 
Actual
           
Numerator:
           
Net loss attributable to common stockholders
  $ (390,742 )   $ (2,312,437 )
                 
Denominator:
               
Weighted average common shares
    436,938,513       222,189,477  
                 
Basic net loss per common share
  $ (0.00 )   $ (0.01 )
                 
Historical outstanding anti-dilutive securities not included in diluted net loss per share calculation
         
Convertible debt
    614,311,820       31,311,942  
Common stock options
    44,136,929       7,355,713  
Common stock warrants
    72,000,000       15,000,000  
      730,448,749       53,667,655  
 
5

 

NOTE 6 – NOTES PAYABLE
           
Notes payable consist of the following: 
           
   
March 31, 2011
   
December 31, 2010
 
Note payable, unsecured, to shareholder at 5% interest, payable upon demand
    61,650       61,650  
Note payable, unsecured, to officer at 5% interest, payable upon demand
    -       205,111  
      61,650       266,761  
Less current portion
    61,650       266,761  
Long term portion
    -       -  
                 

NOTE 7 – CONVERTIBLE NOTES AND DEBENTURES PAYABLE
           
Convertible debt consists of the following:
           
  
           
   
March 31, 2011
   
March 31, 2010
 
Convertible notes issued to an investor, net of discount of  $0 as of March 31, 2011
  $ -     $ 125,000  
Convertible notes issued to an investor, net of discount of  $0 as of March 31, 2011
    0       213,985  
Convertible notes issued to an investor, net of discount of $10,718 as of March 31, 2011
    242,816       -  
Convertible debentures issued to investors, net of discount of $922,350 and $1,037,700, as of March 31, 2011 and December 31, 2010, respectively
    531,050       115,300  
Convertible notes issued to an investor, net of discount of $11,919 as of March 31, 2011
    170,973       -  
Convertible notes issued to an investor, net of discount of  $0 as of March 31, 2011
    125,000       -  
Convertible notes issued to an investor, net of discount of $80,839 as of March 31, 2011
    109,161       -  
Convertible notes issued to an investor, net of discount of  $0 as of March 31, 2011
    75,000       -  
Convertible notes issued to an investor, net of discount of $10,462 as of March 31, 2011
    2,038       -  
      1,256,038       454,285  
Less current portion
    724,988       276,485  
Long term portion
    531,050       177,800  
                 

 
NOTE 8 – OPTIONS AND WARRANTS
 
Options and warrants generally vest immediately upon grant.  The Company has historically issued warrants related to raising capital.  As of March 31, 2011, the Company has 44,136,929 options outstanding and exercisable and 72,000,000 warrants outstanding and exercisable.
 
 
Information about stock options and warrants outstanding at March 31, 2011 and December 31, 2010 is summarized below:
 
                                     
   
Shares
   
Weighed Average Exercise Price Per Share
   
Weighed Average Remaining Contractual Life
 
         
Stock
         
Stock
         
Stock
 
   
Warrants
   
Options
   
Warrants
   
Options
   
Warrants
   
Options
 
Outstanding at December 31, 2010
    72,000,000       44,136,929       0.750       0.060       3.2       3.2  
Granted
    -       -       -       -       -       -  
Exercised
    -       -       -       -       -       -  
Cancelled or Expired
    -       -       -       -       -       -  
Outstanding at March 31, 2011
    72,000,000       44,136,929       0.750       0.060       3.0       3.0  
Exercisable at March 31, 2011
    72,000,000       44,136,929       0.750       0.060       3.0       3.0  


NOTE 9 - OPERATING LEASES AND OTHER COMMITMENTS AND CONTINGENCIES
 
Rental of office space and data processing equipment under operating leases were approximately $4,500 and $23,907 for the three months ended March 31, 2011 and 2010, respectively.
 
NOTE 10 - RELATED PARTY TRANSACTIONS
 
Not applicable
 
NOTE 11 - SUBSEQUENT EVENTS

On April 4, 2011 the Company issued a Convertible Promissory Note in the amount of $12,500.  The Note is due October 4, 2011  Have convertibility features been established?  If yes,  discuss.

On April 7, 2011 the Company issued a Convertible Promissory Note in the amount of $7,500.  The Note is due October 7, 2011.

On April 7, 2011 the Company issued a Convertible Promissory Note in the amount of $7,500.  The Note is due October 7, 2011.

On May 5, 2011 the Company issued a Convertible Promissory Note in the amount of $10.000.  The Note is due November 5, 2011.

On May 5, 2011 the Company created a wholly owned subsidiary, Tomorrows Lighting, Inc., a Nevada corporation and transferred its lighting patents to the new corporation.

 
 
6

ITEM 2. - Management’s Discussion and Analysis of Financial Condition and Results of Operations

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

    Certain statements in this quarterly report on Form 10-Q contain or may contain forward-looking statements that are subject to known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Generally, the words “believes”, “anticipates,” “may,” “will,” “should,” “expect,” “intend,” “estimate,” “continue,” and similar expressions or the negative thereof or comparable terminology are intended to identify forward-looking statements which include, but are not limited to, statements concerning the Company’s expectations regarding its working capital requirements, financing requirements, business prospects, and other statements of expectations, beliefs, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts. These forward-looking statements were based on various factors and were derived utilizing numerous assumptions and other factors that could cause our actual results to differ materially from those in the forward-looking statements. These factors include, but are not limited to, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk, U.S. and global competition, and other factors. Most of these factors are difficult to predict accurately and are generally beyond our control. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. Readers should carefully review this quarterly report in its entirety, including but not limited to our financial statements and the notes thereto. Except for our ongoing obligations to disclose material information under the Federal securities laws, we undertake no obligation to release publicly any revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events. For any forward-looking statements contained in any document, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.
 

THE FOLLOWING DISCUSSION OF THE RESULTS OF OUR OPERATIONS AND FINANCIAL CONDITION SHOULD BE READ IN CONJUNCTION WITH OUR FINANCIAL STATEMENTS AND THE NOTES THERETO INCLUDED ELSEWHERE IN THIS REPORT.
 
Background
 
The Company is engaged in developing, marketing, licensing and contract manufacturing of fluorescent lighting technology for use in residential, commercial and industrial applications.
 
The quest for increased energy efficiency in commercial and industrial lighting applications is growing and demand for dimmable linear fluorescent lighting is expected to expand during the coming years. Our goal is to expand the product line, marketing efforts and sales of multiple lines of dimmable linear fluorescent products.  Our objective is to offer a diverse commercial/industrial product line and take advantage of demonstrated needs in the marketplace.   The Company believes interest in its dimmable CFLs will increase when the Company is capable of offering a full line of bulbs to include multiple styles and wattages which address varying consumer demands. Due to financial constraints, we have not been able to pursue these market opportunities and there can be no assurance that we will be able to implement our business strategy at any time in the future.
 
Our lack of working capital has adversely affected product development and manufacturing of both proprietary and non-proprietary Compact Fluorescent Lamps (CFL).
 
Our products were initially sold through distributors.  We were not successful and changed our business plan to  focus  on Internet sales and other direct marketing methods.  In order to finance its ongoing operations, the Company executed multiple secured convertible promissory notes with several creditors.   The secured creditors filed U.C.C. security interests encumbering all of the Company’s assets now owned or hereafter acquired and the proceeds thereof.  The secured convertible promissory notes are in default.
 
                                  The Company will continue to look into various financing opportunities.  However, there is no assurance that additional financing will be available to us when needed or if available, that it can be obtained on commercially reasonable terms. If we are not able to obtain additional financing on a timely basis, we will not be able to meet our obligations as they become due and we will be forced to decrease or cease operations.  The issuance of additional equity securities by us could result in significant dilution in the equity interests of our current stockholders. Obtaining additional loans, including commercial loans, assuming those loans would be available, will increase our liabilities and future cash commitments

 
Results of Operations:   For the Three ended March 31, 2011 and 2010
 
Revenues
 
For the three months ended March 31, 2011, we recognized $25,682 in revenues compared to $9,079 in revenue for the three months ended March 31, 2010.
 
Expenses
 
For the three months ended March 31, 2011, our expenses were $89,826 compared with $1,605.237 for the three months ended March 31, 2010.  These expenses were primarily comprised of professional and consulting fees ($15,000 for 2011 compared to $389,877 for 2010), compensation ($47,498 for 2011 compared to $326,703 for 2010), other general and administrative expenses ($27,328 for 2011 compared to $331,553 for 2010).
 
Net Income (loss)
 
For the three months ended March 31, 2011, our net loss was $390,742 compared with a net loss of $2,312,437 for the three months ended March 31, 2010.
 
Liquidity and Capital Resources

As of March 31, 2011, we had a working capital deficit of $2,684,500.  This compares to a working capital deficit of $2,560,437 as of December 31, 2010.  Cash on hand was $1,762 compared to cash of $31,294 as of December 31, 2010.  Inventories were $31,294 and $69,568 as of March 31, 2011 and December 31, 2010, respectively.  Accounts payable as of March 31, 2011 were $1,253,659 compared to $1,263,065 as of December 31, 2010.  Current portion of convertible notes payable as of March 31, 2011 were $724,988 and compares to $591,540 as of December 31, 2010.
 
Going Concern
 
Our financial statements contain a note regarding concern about our ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of that uncertainty.
 
Off Balance Sheet Arrangements
 
None
 
Critical Accounting Policies
 
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date the financial statements and the reported amounts of revenue and expenses during the period. Accordingly, actual results could differ from those estimates.  Note 1 of the “Notes to Financial Statements” in our annual report on Form 10-K for the year ended December 31, 2010, includes a summary of the significant accounting policies and methods used in the preparation of our financial statements.  For the period ended March 31, 2011, there were no significant changes to our critical accounting policies.
 
7

 
 
ITEM 3. - Quantitative And Qualitative Disclosures About Market Risk
 
Not applicable.
 
ITEM 4. - Controls and Procedures.
 
(a)           Disclosure Controls and Procedures.
 
Management’s Report on Internal Control over Financial Reporting.
 
The Company’s management conducted an evaluation of the effectiveness of its internal control over financial reporting as of March 31, 2011 using the criteria set forth in the Internal Control over Financial Reporting - Guidance for Smaller Public Companies issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based upon the evaluation, Management concluded that the Company’s internal control over financial reporting was not effective as of March 31, 2011, because of material weaknesses in its internal control over financial reporting.  
 
A material weakness is a control deficiency that results in a more than remote likelihood that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by employees in the normal course of their assigned functions. Management concluded that we have several material weaknesses in our internal control over financial reporting because of inadequate segregation of duties over authorization, review and recording of transactions as well as the financial reporting of such transactions. Due to the Company's limited resources, management has not developed a plan to mitigate the above material weaknesses without the assistance of an independent escrow agent.  In furtherance thereof, and with the agreement of the secured creditors,  all  monies received from either product sales or from any financing, are deposited in an attorney’s escrow account established by the Company at the request of the secured creditors.  Distributions from the escrow account must be approved by the secured creditors
 
 Despite the existence of these material weaknesses, we believe the financial information presented herein is materially correct and in accordance with the generally accepted accounting principles.
 

 
 (b)           Changes in Internal Control over Financial Reporting.
 
Except as set forth above, there have been no changes in the Company’s processes and procedures during the three months ended March 31, 2011, that materially affected or is reasonably expected to materially affect the Company’s internal control over financial reporting.
 

(c)            Inherent Limitations of Disclosure Controls and Internal Controls over Financial Reporting

Because of its inherent limitations, internal controls over financial reporting may not prevent or detect misstatements. Projections of any evaluation or effectiveness to future periods are subject to risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
 

 
PART II
 
ITEM 1. - Legal Proceedings
 
On February 16, 2011 we were sued in the Superior Court of Los Angeles County by Arcata Electronics, Inc.  (Case No, YCO64215).  The suit alleges breach of two purchase and sales agreements in connection with the purchase and sale of electronic goods.  The Plaintiff seeks $170,000 in connection with the purchase and sale of the electronic goods plus related costs.
 
We are currently in settlement negotiations.  If we cannot come to a negotiated settlement,  we do not believe that we will have sufficient resources to defend this action in court.
 
ITEM 1A.  Risk Factors
 

There have been no material changes in our risk factors from those disclosed in our Annual Report on Form 10-K for the period ended December 31, 2010.
 
 
ITEM 2.  Unregistered Sales of Equity Securities and Use of Proceeds

During the three months ended March 31, 2011 the company issued 52,500,000 common shares to satisfy outstanding debt obligations

At all times relevant:

- the  sale  was  made  to  a  sophisticated  or  accredited  investor;

-  we gave the purchaser the opportunity to ask questions and receive answers concerning  the terms and conditions of the offering and to obtain any additional information which we possessed or could acquire without unreasonable effort or expense that is necessary to verify the accuracy of information furnished;

- at a reasonable time prior to the sale of securities, we advised the purchaser of  the  limitations on resale of the securities; and

- neither we nor any person acting on our behalf sold the securities by any form of general solicitation or general advertising

In issuing  the foregoing securities,  we relied on the exemptive provisions of Section 4(2) or Regulation  D of the Securities Act.

 
 
8

 

 
ITEM 3.  Defaults Upon Senior Securities
 

On October 29, 2010 , the Company entered a Forbearance  Agreement (the "Agreement")  with its secured creditors. In order to finance its ongoing operations, the Company  executed multiple secured convertible promissory notes  totaling $756,436with several  creditors.

These notes are in default.

 The secured creditors have filed U.C.C. security interests encumbering all of the Company's assets now owned or hereafter acquired and the proceeds thereof.  Barclay Lyons, LLC  has a priority security interest.


 
ITEM 4 - [Removed and Reserved]
 
ITEM 5. -  Other Information
 
There is no information that was required to be disclosed by the Company on Form 8-K during the first quarter of 2011, that was not reported.
 
ITEM 6. - Exhibits
31.1
Certification of Chief Executive Officer
31.2
Certification of Chief Financial Officer
32.1
Certifications of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2      Certifications of the Chief Financial Officer pursuant   to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002

                                           




 
SIGNATURES
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
PURESPECTRUM, INC.
 By:    
 /s/Gregory Clements
Gregory Clemen
President/CEO and CFO
(Principal Executive Officer)
 
DATE:  May  23, 2011